Yoshida H - Search Results

1

Interaction between PKR and PACT mediated by LPS-inducible NF-κB in human gingival cells.

Yoshida K, Okamura H, Hoshino Y, Shono M, Yoshioka M, Hinode D, Yoshida H. Yoshida K, et al. Among authors: yoshida h. J Cell Biochem. 2012 Jan;113(1):165-73. doi: 10.1002/jcb.23340. J Cell Biochem. 2012. PMID: 21882225

2

PKR-mediated degradation of STAT1 regulates osteoblast differentiation.

Yoshida K, Okamura H, Amorim BR, Hinode D, Yoshida H, Haneji T. Yoshida K, et al. Among authors: yoshida h. Exp Cell Res. 2009 Jul 15;315(12):2105-14. doi: 10.1016/j.yexcr.2009.02.003. Epub 2009 Feb 20. Exp Cell Res. 2009. PMID: 19230833

3

PKR plays a positive role in osteoblast differentiation by regulating GSK-3β activity through a β-catenin-independent pathway.

Yoshida K, Okamura H, Ochiai K, Hoshino Y, Haneji T, Yoshioka M, Hinode D, Yoshida H. Yoshida K, et al. Among authors: yoshida h. Mol Cell Endocrinol. 2012 Sep 25;361(1-2):99-105. doi: 10.1016/j.mce.2012.03.019. Epub 2012 Apr 5. Mol Cell Endocrinol. 2012. PMID: 22484461

4

Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.

Harada K, Supriatno, Yoshida H, Sato M. Harada K, et al. Among authors: yoshida h. Int J Oncol. 2005 Dec;27(6):1489-97. Int J Oncol. 2005. PMID: 16273203

5

S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.

Harada K, Supriatno, Kawashima Y, Yoshida H, Sato M. Harada K, et al. Among authors: yoshida h. Int J Oncol. 2007 Feb;30(2):365-74. Int J Oncol. 2007. PMID: 17203218

6

Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells.

Harada K, Supriatno, Kawashima Y, Itashiki Y, Yoshida H, Sato M. Harada K, et al. Among authors: yoshida h. Oral Oncol. 2005 Jul;41(6):623-30. doi: 10.1016/j.oraloncology.2005.02.007. Oral Oncol. 2005. PMID: 16050017

7

Overexpression of p27(Kip1) induces growth arrest and apoptosis in an oral cancer cell line.

Supriatno, Harada K, Hoque MO, Bando T, Yoshida H, Sato M. Supriatno, et al. Among authors: yoshida h. Oral Oncol. 2002 Oct;38(7):730-6. doi: 10.1016/s1368-8375(02)00011-8. Oral Oncol. 2002. PMID: 12167427

8

Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.

Okamoto M, Ohe G, Furuichi S, Nishikawa H, Oshikawa T, Tano T, Ahmed SU, Yoshida H, Moriya Y, Matsubara S, Ryoma Y, Saito M, Sato M. Okamoto M, et al. Among authors: yoshida h. Anticancer Res. 2002 Nov-Dec;22(6A):3229-39. Anticancer Res. 2002. PMID: 12530069

9

Cytoplasmic TSC-22 (transforming growth factor-beta-stimulated clone-22) markedly enhances the radiation sensitivity of salivary gland cancer cells.

Hino S, Kawamata H, Omotehara F, Uchida D, Miwa Y, Begum NM, Yoshida H, Sato M, Fujimori T. Hino S, et al. Among authors: yoshida h. Biochem Biophys Res Commun. 2002 Apr 12;292(4):957-63. doi: 10.1006/bbrc.2002.6776. Biochem Biophys Res Commun. 2002. PMID: 11944908

10

Characteristics of antitumor activity of mutant type p27Kip1 gene in an oral cancer cell line.

Supriatno, Harada K, Kawaguchi S, Onoue T, Yoshida H, Sato M. Supriatno, et al. Among authors: yoshida h. Oral Oncol. 2004 Aug;40(7):679-87. doi: 10.1016/j.oraloncology.2004.01.002. Oral Oncol. 2004. PMID: 15172637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,985 results

Search Page

Filters